We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J Unit Asserts Bladder Drug Patent Again

Law360 (August 22, 2006, 12:00 AM EDT) -- Still trying to fend off allegations of anti-competitive behavior over Ditropan XL, Johnson & Johnson subsidiary Alza Corporation has hit Mylan Laboratories Inc. with another patent infringement lawsuit involving the blockbuster...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.